BP Midstream Partners LP owns, acquires, develops, and operates pipelines and other midstream assets in the United States. Its assets consist of interests in entities that own crude oil, natural gas, refined products, and diluent pipelines as well as refined product terminals. BP Midstream Partners GP LLC serves as a general partner of BP Midstream Partners LP. The company was incorporated in 2017 and is based in Houston, Texas.
IPO Year: 2017
Exchange: NYSE
Date | Price Target | Rating | Analyst |
---|---|---|---|
3/1/2022 | $15.58 → $16.00 | Neutral → Sell | Citigroup |
8/20/2021 | $16.00 → $13.50 | Buy → Neutral | Mizuho |
8/18/2021 | $16.00 → $13.70 | Buy → Neutral | UBS |
8/10/2021 | Buy → Hold | JonesTrading | |
8/6/2021 | $17.00 → $14.00 | Neutral → Underweight | JP Morgan |
New senior leadership tapped to strengthen commercial relationship with bp, expand footprint in Europe, and establish an advanced technology center in Colorado FreeWire Technologies ("FreeWire"), a category leader in electric vehicle (EV) charging and power solutions, today announced that it has appointed Craig Coburn to its Board of Directors, Martin Bax to the role of Director of European Market Development, and John Seabury to the role of Vice President of Advanced Technology. Following a decades-long career at bp, most recently as the CFO for bp Midstream Partners (NYSE:BPMP) and CFO for bp America, Coburn brings extensive experience in energy finance, technology commercialization, pl
LEAWOOD, KS / ACCESSWIRE / April 4, 2022 / TortoiseEcofin today announced that BP Midstream Partners LP (NYSE:BPMP) will be removed from the Tortoise MLP Index® (TMLP), and the Tortoise North American Pipeline IndexSM (TNAP), as a result of the approved merger with bp plc (NYSE:BP). Due to the merger, BPMP will be removed from both indices at market open on Tuesday, April 5, 2022.For Tortoise MLP Index® (TMLP), BPMP will be removed with a special rebalancing. BPMP will be dropped from Tortoise North American Pipeline IndexSM (TNAP) without special rebalancing.Special rebalancings in each of TMLP and TNAP are triggered by corporate actions such as mergers, bankruptcies, liquidations, and conv
New senior leadership tapped to strengthen commercial relationship with bp, expand footprint in Europe, and establish an advanced technology center in Colorado FreeWire Technologies ("FreeWire"), a category leader in electric vehicle (EV) charging and power solutions, today announced that it has appointed Craig Coburn to its Board of Directors, Martin Bax to the role of Director of European Market Development, and John Seabury to the role of Vice President of Advanced Technology. Following a decades-long career at bp, most recently as the CFO for bp Midstream Partners (NYSE:BPMP) and CFO for bp America, Coburn brings extensive experience in energy finance, technology commercialization, pl
DALLAS, Dec. 31, 2020 /PRNewswire/ -- Cushing® Asset Management, LP, and Swank Capital, LLC, announce today the upcoming rebalancing of The Cushing® MLP High Income Index (the "Index") as part of normal index operations. After the markets close on January 8, 2021, the 30 constituents of the Index will be rebalanced, and the following changes will become effective on January 11, 2021: Constituents added:BP Midstream Partners LP (NYSE: BPMP)Equitrans Midstream Corporation (NYSE: ETRN) Constituents removed:Enviva Partners, LP (NYSE: EVA)NGL Energy Partners LP (NYSE: NGL) ABOUT THE CUSHING® MLP HIGH INCOME INDEX The Cushing® MLP High Income Index provides a benchmark that is designed to track
SC 13D/A - BP Midstream Partners LP (0001708301) (Subject)
SC 13G/A - BP Midstream Partners LP (0001708301) (Subject)
SC 13G/A - BP Midstream Partners LP (0001708301) (Subject)
SC 13D/A - BP Midstream Partners LP (0001708301) (Subject)
SC 13D/A - BP Midstream Partners LP (0001708301) (Subject)
SC 13G/A - BP Midstream Partners LP (0001708301) (Subject)
SC 13G/A - BP Midstream Partners LP (0001708301) (Subject)
SC 13G/A - BP Midstream Partners LP (0001708301) (Subject)
SC 13G/A - BP Midstream Partners LP (0001708301) (Subject)
SC 13D/A - BP Midstream Partners LP (0001708301) (Subject)
Citigroup downgraded BP Midstream Partners from Neutral to Sell and set a new price target of $16.00 from $15.58 previously
Mizuho downgraded BP Midstream Partners from Buy to Neutral and set a new price target of $13.50 from $16.00 previously
UBS downgraded BP Midstream Partners from Buy to Neutral and set a new price target of $13.70 from $16.00 previously
JonesTrading downgraded BP Midstream Partners from Buy to Hold
JP Morgan downgraded BP Midstream Partners from Neutral to Underweight and set a new price target of $14.00 from $17.00 previously
Morgan Stanley reiterated coverage of BP Midstream Partners with a rating of Equal-Weight and set a new price target of $15.00 from $14.00 previously
JP Morgan upgraded BP Midstream from Neutral to Overweight and set a new price target of $16.00
Morgan Stanley reiterated coverage of BP Midstream Partners with a rating of Equal-Weight and set a new price target of $14.00 from $13.00 previously
15-12B - BP Midstream Partners LP (0001708301) (Filer)
S-8 POS - BP Midstream Partners LP (0001708301) (Filer)
8-K - BP Midstream Partners LP (0001708301) (Filer)
25-NSE - BP Midstream Partners LP (0001708301) (Subject)
10-K - BP Midstream Partners LP (0001708301) (Filer)
DEFM14A - BP Midstream Partners LP (0001708301) (Filer)
8-K - BP Midstream Partners LP (0001708301) (Filer)
425 - BP Midstream Partners LP (0001708301) (Subject)
425 - BP Midstream Partners LP (0001708301) (Subject)
8-K - BP Midstream Partners LP (0001708301) (Filer)
According to Benzinga Pro, during Q4, BP Midstream Partners (NYSE:BPMP) earned $46.10 million, a 33.24% increase from the preceding quarter. BP Midstream Partners also posted a total of $34.70 million in sales, a 31.94% increase since Q3. In Q3, BP Midstream Partners earned $34.60 million, and total sales reached $26.30 million. What Is ROCE? Return on Capital Employed is a measure of yearly pre-tax profit relative to capital employed by a business. Changes in earnings and sales indicate shifts in a company's ROCE. A higher ROCE is generally representative of successful growth of a company and is a sign of higher earnings per share in the future. A low or negative ROCE suggests the opposite
Upgrades Stifel upgraded the previous rating for Revolution Medicines Inc (NASDAQ:RVMD) from Hold to Buy. For the fourth quarter, Revolution Medicines had an EPS of $0.71, compared to year-ago quarter EPS of $0.52. The stock has a 52-week-high of $50.88 and a 52-week-low of $18.07. At the end of the last trading period, Revolution Medicines closed at $18.92. According to UBS, the prior rating for Amedisys Inc (NASDAQ:AMED) was changed from Sell to Neutral. For the fourth quarter, Amedisys had an EPS of $1.18, compared to year-ago quarter EPS of $1.49. At the moment, the stock has a 52-week-high of $292.97 and a 52-week-low of $122.12. Amedisys closed at $160.24 at the end of the last trad
Citigroup analyst Ryan Levine downgrades BP Midstream Partners (NYSE:BPMP) from Neutral to Sell and raises the price target from $15.58 to $16.
On CNBC’s "Mad Money Lightning Round," Jim Cramer said he likes Penn National Gaming, Inc. (NASDAQ:PENN), calling the stock as a winner. "We know those [gambling] stocks have been in a terrible war, so don’t expect anything near term, but I do like Penn Nat," he added. Cramer recommended buying Vericel Corporation (NASDAQ:VCEL), saying, "They actually have revenue…They’ve got good technology." When asked about Plug Power Inc. (NASDAQ:PLUG), the Mad Money host said, "the reason why it’s down is because we don’t like the speculative stocks anymore." Cramer said, "You take profits on that…You win the lottery on that one," when asked about BP Midstream Partners LP (NYSE:BPMP). Cramer s
Gainers Society Pass Incorporated (NASDAQ:SOPA) shares climbed 240.2% to close at $11.26 on Monday after the company reported addition to the Russell 2000 Index. Bluerock Residential Growth REIT, Inc. (NYSE:BRG) surged 76.2% to close at $27.20. Blackstone agreed to buy Bluerock Residential Growth REIT in a deal valued at $3.6 billion, extending its push into U.S. rental housing. Can-Fite BioPharma Ltd. (NYSE:CANF) rose 69.3% to settle at $2.15 after the company announced a liver cancer patient was cleared of all cancer lesions. Verso Corporation (NYSE:VRS) shares jumped 34.9% to close at $27.04 after the company announced it would be acquired by BillerundKorsnas for $27 per share. A
Gainers Society Pass Incorporated (NASDAQ:SOPA) shares jumped 120.9% to $7.31 after the company reported addition to the Russell 2000 Index. Can-Fite BioPharma Ltd. (NYSE:CANF) gained 74.4% to $2.2150 after the company announced a liver cancer patient was cleared of all cancer lesions. Bluerock Residential Growth REIT, Inc. (NYSE:BRG) jumped 70.2% to $26.28. Blackstone agreed to buy Bluerock Residential Growth REIT in a deal valued at $3.6 billion, extending its push into U.S. rental housing. Galera Therapeutics, Inc. (NASDAQ:GRTX) gained 37.5% to $4.07. Citigroup maintained Galera Therapeutics with a Buy and raised the price target from $11 to $20. Verso Corporation (NYSE:VRS) shar
-Reuters
4 - BP Midstream Partners LP (0001708301) (Issuer)
4 - BP Midstream Partners LP (0001708301) (Issuer)
4 - BP Midstream Partners LP (0001708301) (Issuer)
4 - BP Midstream Partners LP (0001708301) (Issuer)
4 - BP Midstream Partners LP (0001708301) (Issuer)
4 - BP Midstream Partners LP (0001708301) (Issuer)
4 - BP Midstream Partners LP (0001708301) (Issuer)
4 - BP Midstream Partners LP (0001708301) (Issuer)
4 - BP Midstream Partners LP (0001708301) (Issuer)
4 - BP Midstream Partners LP (0001708301) (Issuer)